Results 111 to 120 of about 297,165 (214)

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens

open access: yesmAbs
Redirection of T lymphocytes toward cancer cells has been one of the most promising treatment concepts in oncology developed over the past years and leading to multiple regulatory approvals for both adoptive cell therapy (ACT) and T-cell-engaging ...
Martin Hofmann   +16 more
doaj   +1 more source

The Role of CD19 and CD27 in the Diagnosis of Multiple Myeloma by Flow Cytometry: A New Statistical Model

open access: yes, 2011
We have developed a new statistical diagnostic model that examines the correlation between immunophenotype and clonality as detected by flow cytometry (FC) and histology, defining the diagnostic role of FC in multiple myeloma (MM).
Preffer F.   +13 more
core   +1 more source

Engineering a CD19-Based Bispecific Molecule for CAR T Cell Therapy

open access: yes, 2018
University of Minnesota M.S. thesis. October 2018. Major: Biomedical Engineering. Advisor: Benjamin Hackel. 1 computer file (PDF); vii, 101 pages.Cancer is a profoundly devastating disease both globally and within the United States. Current standards of
Schrack, Ian
core  

Fig. 1 E

open access: yes
Raw data / images used in Fig 1E. We provide data for1) CD19 BBz CAR T-cells (labeled as CD19) on different supported lipid bilayers featuring different antigen densities (18.4, 0.65 and 0.012 molecules /µm2) and acquired DIC/ bright field images ...
Vanessa Mühlgrabner (18460053)
core   +1 more source

CAR T-Cell Therapy in Hematological Malignancies: Mechanisms, Innovations, and Challenges. [PDF]

open access: yesCancers (Basel)
Aljabali AAA   +11 more
europepmc   +1 more source

Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance

open access: yes, 1993
A portion of patients with acute myeloid leukemia also display surface antigens associated with lymphoid development (Ly+AML). The incidence of Ly+AML varies considerably between independent studies, both overall and with regard to individual antigens ...
Thiel, E., Drexler, H.G., Ludwig, W.D.
core  

Development of a Novel Anti-CD19 Chimeric Antigen Receptor

open access: yes
Genetically modifying autologous T cells to express an anti-CD19 chimeric antigen receptor (CAR) has shown impressive response rates for the treatment of CD19+ B cell malignancies in several clinical trials (CTs). Making this treatment available to our patients prompted us to develop a novel CART19 based on our own anti-CD19 antibody (A3B1), followed ...
Castellà, Maria   +32 more
openaire   +1 more source

CD21 and CD19: how B cells sense antigen [PDF]

open access: yesClinical and Experimental Immunology, 1994
openaire   +1 more source

Seronegative spondyloarthropathies and HLA antigens in a Mestizo population

open access: yes, 1984
HLA-A and -B antigens incidence were investigated in 100 cases of Seronegative Spondyloarthropathies and in 303 control individuals of a Venezuelan Mestizo population.
Bianco Colmenares, Nicolás E.   +3 more
core  

Home - About - Disclaimer - Privacy